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Modulation of host cell signaling and cellular functions is key to intracellular survival of pathogenic bacteria.
Intracellular growth has several advantages e.g. escape from the humoral immune response and access to a stable
nutrient rich environment. Growth in such a preferred niche comes at the price of an ongoing competition
between the bacteria and the host as well as other microbes that compete for the very same host resources. This
requires specialization and constant evolution of dedicated systems for adhesion, invasion and accommodation.
Interestingly, obligate intracellular bacteria of the order Chlamydiales have evolved an impressive degree of control
over several important host cell functions. In this review we summarize how Chlamydia controls its host cell with a
special focus on signal transduction and cellular modulation.
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Chlamydia trachomatis is an important human patho-
gen and the best investigated member of the order
Chlamydiales [1]. Infection with C. trachomatis is among
the most frequent causes of sexual transmitted diseases
(STD). Infections of the upper inner eyelid eventually lead-
ing to scarring blindness (trachoma) are worldwide among
the most frequently occurring ocular infections with nearly
140 million infected and 500 million at risk (source
WHO). C. pneumoniae is a common agent of respiratory
disease with sero-positivity as high as 30-45% in adults
[2,3] and association with chronic diseases like arterioscler-
osis or lung cancer [4,5].
Chlamydiae are obligate intracellular bacteria with a
gram-negative atypical cell wall [6]. Growth is characterized
by a distinct biphasic cycle of development. The extracellu-
lar infectious elementary bodies (EB) adhere and upon in-
ternalization into the host cell start an infectious cycle.
Once internalized, EB quickly differentiate into metabolic-
ally active, dividing reticulate bodies (RB). The common
perception of EB as metabolically inactive has recently been
challenged by the discovery of developmental form specific
metabolic requirements [7]. Adherence of an EB to the
host cell is mediated by bacteria-host receptor interactions* Correspondence: thomas.rudel@biozentrum.uni-wuerzburg.de
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distribution, and reproduction in any mediumthat initiate signaling via the adhesin-bound receptor and
concomitantly by other bacterial effector proteins to trigger
the rapid internalization of the bacteria [8-12]. Bacterial
uptake leads to formation of a heavily modified pathogen
containing vacuole termed inclusion [13]. Modification of
the inclusion is required to prevent endolysosomal fusion
and to direct acquisition of various metabolites or nutrients
e.g. iron or sphingomyelin [14-17]. At the end of the infec-
tious cycle Chlamydia is released from the host cell by
lysis or a process that has been termed extrusion [18,19].
Chlamydia is able to enter a reversible persistent state
through limitation of either nutrients (e.g. iron, amino
acids) or application of antibiotics (e.g. penicillin) [20,21].
Persistence is characterized by formation of aberrant bod-
ies, an incomplete developmental cycle, ongoing metabolic
activity and altered gene expression [22,23]. Upon removal
of the persistence inducer Chlamydia can reactivate and
enter an acute developmental cycle.
Modulation of various host cell processes by Chlamydia
is a prerequisite to complete the developmental cycle.
Manipulation of the host cell requires specialized secretion
systems e.g. the type three secretion system (TTSS) and
its effector proteins and the respective genes for the
TTSS can be found in all sequenced chlamydial genomes
[24,25]. Other factors include e.g. the adhesins/invasins
polymorphic membrane protein D (PmpD) [12,26] and
outer membrane complex B (OmcB) [27]. Here, we reviewentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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effectors and sort both according to infection time and
intracellular location. We apologize to all the authors,
whose work could not be discussed in this review due to
space constraints. For in depth reading we refer the inter-
ested reader to a recently published book [28].
Adhesion
Efficient adhesion to host cells is a prerequisite for invasion
and intracellular life and usually requires several adhesins.
Chlamydia has evolved a number of ways to attach to vari-
ous host cells and infect different tissues according to sero-
variant and species [29,30]. Early research focused on the
role of the abundant major outer membrane protein
(MOMP) as an adhesin [31] (Figure 1A-B). Blocking the
exposed variable MOMP domains using specific antibodies
disturbed binding to the host cell [32]. Chlamydia
muridarum MOMP has been described to mediate attach-
ment to host cells as a cytoadhesin [33]. Further, MOMP
from various chlamydial species is glycosylated (mainly D-
mannose-rich) and this modification is critical for MOMP
adhesion [34-36]. The mannose-6-phosphate / insulin-like
growth factor receptor 2 (M6PR/IGFR2) has been sug-
gested as the host receptor for MOMP, since the MOMP
glycan moiety is similar to the M6PR ligand mannose-6-
phosphate and blocking the M6PR prevents C. pneumoniae
attachment and invasion [37].
Also, heparan sulfate-like glycosaminoglycan (GAG) at-
tached to Chlamydia has been shown to bridge host and
bacterium [38] (Figure 1A-B). Cleaving this GAG com-
pound from the bacteria renders them non-adhesive, while
addition of exogenous heparan sulfate restored attach-
ment. GAG of a size similar to heparin or heparan sulfate
has subsequently been found in the inclusion produced by
Chlamydia [39]. Chlamydial synthesis of GAG is consist-
ent with the observation that C. trachomatis also infects
CHO cells deficient in heparin sulfate biosynthesis [40].
Outer membrane complex B (OmcB), a cysteine rich
membrane protein, has been described to bind to GAG
[41,42]. Further, GAG binding varies depending on the
specific serovariant [27,43] and this binding has recently
been attributed to a strain specific motif within the N-
terminus of OmcB [44]. Variation in GAG binding has
been suggested to co-determine cell type specificity [45].
Most of the studies performed so far on Chlamydia-
host binding focused on bacterial adhesins and only lim-
ited data are available on the nature of host cell receptor
(s). Correct surface presentation of specific host proteins
has been suggested to be important using CHO cells ex-
pressing a defective protein disulfide isomerase (PDI)
[46,47]. In this model PDI is most likely involved in the
folding, surface presentation or receptor complex forma-
tion (Figure 1A). Attachment of C. trachomatis to host
cells has been shown to require sulfation but no specificreceptors were identified [48]. More recently, epidermal
growth factor receptor (EGFR/ERBB) has been shown to
be the host receptor for C. pneumoniae Pmp21, but not
Pmp21 of C. trachomatis [12] (Figure 1A-B). Residual
adhesion and invasion upon EGFR depletion indicates
that other receptors are involved in adherence [12]. In
case of C. trachomatis, lipopolysaccharide (LPS) has
been demonstrated to be a ligand for the human cystic
fibrosis transmembrane conductance regulator (CFTR)
[49]. The closely related mouse pathogen C. muridarum
engages the Fibroblast growth factor receptor (FGFR)
for invasion. In this case, fibroblast growth factor 2
(FGF2) binds to C. muridarum and mediates invasion
via FGFR [50]. The bacterial ligand for FGFR is still un-
known (Figure 1A).
Adhesion accompanied signaling
Until today a systematic approach to identify host recep-
tors for C. trachomatis and C. pneumoniae e.g. by applying
RNA interference has not been undertaken. One difficulty
may be receptor redundancy that prevents the straightfor-
ward identification of receptors by single knockdowns. On
the bacterial side the upcoming establishment of a genetic
system just recently opened the door to systematic for-
ward genetic searches in Chlamydia. We can learn a lot
about bacteria-induced signaling from the recently discov-
ered adhesin – receptor pair Pmp21 - EGFR [12]. Pmp21
coated latex beads are endocytosed in an EGFR-dependent
manner demonstrating that Pmp21 is sufficient to trigger
invasion [12]. The C. trachomatis homolog PmpD has also
been implicated in adhesion, however direct experimental
evidence for its function as adhesin is still missing [26].
Binding of Pmp21 to EGFR activates the receptor leading
to formation of a complex with the adaptor protein
growth factor receptor bound-2 (Grb2) and the ubiquitin
ligase Cas-Br-M (murine) ecotropic retroviral transform-
ing sequence (c-Cbl). EGFR activation subsequently leads
to extracellular-signal-regulated kinase 1/2 (Erk1/2) activa-
tion [12] (Figure 1B). C. pneumoniae invasion has been
shown to be accompanied by activation of src homology
containing (SHC1), Erk and phosphoinositol 3 kinase
(PI3K) [51]. Apparently, SHC1, Erk and PI3K activation is
initiated by EGFR activation and may together lead to
FAK activation (Figure 1B). Involvement of additional
adhesin – receptor pair is likely and OmcB presents a
strong candidate on the bacterial side because of its hep-
arin sulphate binding domain [27,42].
CFTR has been suggested as a potential host receptor
for C. trachomatis. Binding of LPS to CFTR reduces the
conductance of CFTR, however, the consequences host
signaling is unclear [49] (Figure 1A). C. muridarum
bound to host cells specifically recruits FGFR as well as
platelet derived growth factor receptor (PDGFR), but
not EGFR [50,52]. Activated FGFR and PDGFR lead to
AB
Figure 1 Adhesion induced signaling. A, Adhesin-receptor pairs are ill defined for the closely related pathogens C. trachomatis and C. muridarum.
Several surface proteins like lipopolysaccharide (LPS), major outer membrane protein (MOMP), outer membrane complex B (OmcB) and polymorphic
membrane protein (Pmp21) have been suggested as potential bacterial adhesins. A trimolecular bridge is thought to connect MOMP, OmcB and FGFR
to their host or bacterial counterpart, respectively. Binding to host receptors like fibroblast growth factor receptor (FGFR) or platelet derived growth
factor receptor (PDGFR) induces mitogenic signaling via extracellular-signal-regulated kinase 1/2 (Erk1/2). Receptor surface presentation and folding via
protein disulfide isomerase (PDI) shows the necessity for specific host receptor binding. B, C. pneumoniae binds to its host cell in a bimolecular fashion
via OmcB heparin sufate proteoglycan (HSPG) interaction. Binding between OmcB and HSPG is probably a reversible initial reversible binding step
followed by irreversible specific binding. One adhesin receptor pair involved is Pmp21 – EGFR. The Pmp21 – EGFR interaction then triggers invasion of
Chlamydia. Further, binding to EGFR also recruits growth factor receptor bound 2 (Grb2), Cas-Br-M (murine) ecotropic retroviral transforming sequence
(c-Cbl), SHC (Src homology 2 domain containing) transforming protein 1 (SHC1) and phosphatidyl-inositol-3-kinase (PI3K) signaling, which initiates
mitogenic Erk1/2 signaling as well as cytoskeletal rearrangements via focal adhesion kinase (FAK). Pmp6 and 20 have been suggested as additional
adhesins on the bacterial side, while insulin growth factor receptor (IGFR) has been indicated on the host side.
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to C. pneumoniae induced EGFR signaling. Require-
ments for FGF2 have also been confirmed in the human
pathogenic strain C. trachomatis E indicating that acti-
vation of FGFR signaling might partially replace EGFR
signaling during C. trachomatis infection [50]. Host re-
ceptors for the MOMP glycan and OmcB GAG inter-
action have not yet been defined. Interestingly, C.trachomatis receptor signaling and recruitment might
be synergistic with signaling induced by the secreted
bacterial protein Tarp [53]. Tarp interacts with several
of the proteins recruited to the EGFR in a serovar- and
phosphorylation-dependent manner [53,54]. Phosphor-
ylation of Tarp in turn is mediated by multiple kinases
most likely Src family kinases as well as Abl kinases
[52,55,56] (Figure 2A).
Figure 2 Cytoskeletal modulation and signaling. A, Invading C. trachomatis is believed to secrete a cocktail of preformed effectors into the
host cell and this is supported by the two discovered factors translocated actin recruiting phosphor protein (Tarp) and CT694. Tarp initiates
multiple signaling cascades, i.e. its N-terminus is phosphorylated on several tyrosine residues (pY) and the C-terminally located actin binding
domains (ABD) mediate actin nucleation and bundling. Signaling via the N-terminus leads to survival signaling via extracellular-signal-regulated
kinase 1/2 (Erk1/2) as well as actin branching via son of sevenless homolog 1 (SOS1) / abl-interactor 1 (Abi1) / epidermal growth factor receptor
pathway substrate 8 (Eps8) / WAS protein family, member 2 (WASF2 alternative name: Wiskott-Aldrich syndrome protein family member
2 - Wave2) and actin related protein 2/3 (Arp2/3) complex. CT694 consists of a membrane binding domain (MBD) and an AHNAK nucleoprotein
(AHNAK) binding region which probably links membrane to actin signaling. B, C. caviae and pneumoniae secrete Tarp which does not contain the
N-terminal tyrosine phosphorylation domain. The C-terminal ABD motives are sufficient for actin bundling and nucleation and some of the func-
tions linked to C. trachomatis Tarp might be executed via epidermal growth factor receptor (EGFR). Activation of the small GTPases ras-related C3
botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) (Rac1) and cell division cycle 42 (GTP binding protein, 25 kDa) (CDC42)
has been shown for C. caviae, the bacterial factors mediating this are not yet found. C. caviae also activates ADP-ribosylation factor 6 (Arf6), which
in turn activates phosphatidyl-inositol-4-kinase (PI4K) and this might take over the membrane-actin modulating function of CT694.
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Initial studies on Chlamydia invasion indicated the in-
volvement of both actin-dependent and -independent
mechanisms. Invasion was suggested to take place either
through phagocytosis- (actin dependent) or pinocytosis-
like (actin independent) processes [57]. These observa-
tions were supported by the differential sensitivity of C.
trachomatis serovariants towards the f-actin disrupting
agent cytochalasin D [58]. However, more and more inves-
tigations focused on actin driven processes. One reason is
that recruitment of actin to the invasion site was directly
shown [59] and found to be dependent on a bacterial
structural component, which was subsequently identified
to be the translocated actin recruiting phosphoprotein
(Tarp) [8,59] (Figure 2A). Tarp is synthesized during the
late stages of infection and is most likely secreted into the
host cell via the TTSS [8,60,61]. Surprisingly, Tarp tyrosine
phosphorylation and actin recruitment are not coupled
[62]. It turned out that Tarp is a nucleator of actin since it
contains several actin-binding domains (ABD) with simi-
larity to WH2 domain proteins. In addition, a proline rich
region in Tarp may enhance actin oligomerization [63].
Tarp-mediated actin binding is conserved across species
and is likely to be required for chlamydial invasion as inva-
sion was blocked by anti-ABD sera [64]. Actin nucleation
and bundling activities are separated in different ABD and
the rate of actin polymerization is synergistic with the host
Arp2/3 complex emphasizing the complexity of bacterially
induced cytoskeletal modulation [65,66] (Figure 2A). Many
pathogens require several cytoskeletal modulators for effi-
cient invasion of their host cells. The chlamydial effector
CT694 was discovered more recently and similarly to Tarp
shows late expression and early secretion [9]. A search for
cellular interaction partners identified the C-terminus of
CT694 as a domain that interacts with host AHNAK and
actin [9]. AHNAK is a localized to the apical plasma mem-
brane where it interacts with actin to maintain the archi-
tecture of polarized cells [9]. In addition, AHNAK plays a
role as a scaffold protein, thereby connecting protein kin-
ase C alpha (PKCα) and phospholipase C gamma (PLCγ)
signaling [9]. The N-terminus contains a membrane lo-
calization domain suggesting that CT694 functions in
actin modulation during invasion [67] (Figure 2A).
Small GTPases are important modulators of actin dy-
namics and downstream signaling and many bacteria
evolved ways to modulate host GTPases. C. trachomatis
requires the small GTPase ras-related C3 botulinum
toxin substrate 1 (Rac1) but not cell division cycle 42
(Cdc42) or ras homolog gene family member A (RhoA)
for invasion [68]. Rac1 has been shown to interact with
abl interactor 1 (Abi1) and WAS protein family, member
2 (WASF2; also known as Wiskott-Aldrich syndrome
protein family member 2 - Wave2) in order to regulate
the actin-related protein complex 2/3 (Arp2/3) and thusmodulates actin recruitment and branching [69]. Activa-
tion of Rac1 might be Tarp dependent as phosphorylated
Tarp interacts with the Abi1 / son of sevenless homolog
1 (SOS1) / epidermal growth factor receptor pathway
substrate 8 (Eps8), vav 2 guanine nucleotide exchange
factor (Vav2) and phosphoinositol 3 kinase (PI3K) up-
stream of Rac1 [53,54]. The requirement of GTPase for
invasion differs among Chlamydia species as C. caviae
needs the small GTPases Rac1 and Cdc42 but not RhoA
during invasion [70] (Figure 2A-B).
Tarp from C. caviae does not possess the phosphoryl-
ation sites required for Rac activation; this suggests that
another bacterial factor for the activation of Rac1 and/or
Cdc42 exists. One pathway to Rac1 activation during C.
pneumoniae invasion could stem from EGFR-mediated
PI3K activation and it is tempting to speculate that EGFR
contributes to Rac1 activation during C. pneumoniae infec-
tion in an analogous fashion as phosphorylated TARP does
during C. trachomatis infection (Figure 2A-B). So far, data
on the role of EGFR for C. caviae and Rho GTPases for C.
pneumoniae infection are still missing, respectively. An-
other GTPase involved in remodeling of the actin cyto-
skeleton during C. caviae invasion is ADP ribosylation
factor 6 (Arf6) [71]. Arf6 activates phosphatidylinositol 4-
phosphate 5-kinase (PI4K) which is important for plasma
membrane modulation during actin rearrangement, sug-
gesting a similar function as has been proposed for CT694.
A bacterial component activating Arf6 has not been de-
scribed and awaits further investigation (Figure 2B).
Establishment of the inclusion
The exact origin of the endosomal membrane is a matter
of ongoing research. Caveolin [72,73], membrane rafts
[73,74] and clathrin-mediated [75,76] endosome forma-
tion have been suggested as entry route for Chlamydia.
However, these findings are still a matter of discussion
since these pathways of endosome formation have not
been confirmed by others [77,78]. This may be partly
due to the use of different chlamydial species in these
reports (C. trachomatis vs. C. pneumoniae vs. C. caviae)
since these species differ not only in their host receptor
but also in their invasion-mediated signaling. Due to
these differences, varying experimental conditions had to
be used e.g. for cell culture infection (centrifuge assisted
vs. static). In analogy to influenza virus entry [79] and
considering actin-dependent and -independent invasion
mechanisms as well as differences in adhesion and entry
signaling between species, a multi-route entry is likely.
Beside the ongoing discussion on the endosomal origin
in Chlamydia infection consensus exists that once the en-
dosome is formed it quickly separates from the endosomal
route and starts to acquire sphingomyelin from the exo-
cytic route [17,80] (Figure 3). Vacuolar pH stays above
6.0 indicating that lysosomal fusion is prevented [81].
Figure 3 Establishment of the inclusion. A, The origin of the endosomal membrane of Chlamydia is not yet solved. Entry via multiple routes
was suggested e.g. clathrin, caveolin or lipid raft dependent. After invasion early inclusions deviate from the endosomal route and acquires
sphingolipids from the basolaterally directed exocytic route. Bacterial factors directing the exocytic trafficking towards the inclusion are not yet
known. Similar to the Golgi (the most important inclusion lipid source) the inclusion pH stays above 6.0. Other lipid sources are via CD63+ late
endosomes/ multivesicular body (LE/MVB), lipid droplets and through recruitment of the high density lipoprotein (HDL) synthesis machinery. EE
(Early endosome), LE (Late endosome), RE (Recycling endosome) and L (Lysosomes). Transport of the inclusion to the microtubule organizing
center (MTOC) requires Src family kinases (SFK), dynein, the dynactin subunit p150 Glued and an unidentified bacterial factor. Positioning and
growth of the inclusion is accompanied by Golgi ministack formation in C. trachomatis. B, Interaction with various cellular organelles is mediated
via a wide set of inclusion membrane proteins. IncG, CT229 and Cpn0585 are among the best investigated Inc proteins shown to interact with
host proteins. Apoptosis is controlled via IncG/14-3-3 beta/ BCL2-associated agonist of cell death (p-Bad) interaction. Organelle identity is probably
mediated via CT229 which interacts with Rab4 and Cpn0585 (interacts with Rab1, 10 and 11). Moreover, Incs segregate into micro domains and
this is often associated with SFK co-localization. ER – inclusion synapses have been suggested to be an additional routes of lipid uptake. This is
mediated via IncD/ collagen, type IV, alpha 3 (Goodpasture antigen) binding protein (CERT) / VAMP (vesicle-associated membrane protein)-associated
protein A, 33 kDa (VAP-A) interaction. CERT is a lipid carrier suggested to transfer ceramide into the inclusion membrane where ceramide is converted
to sphingomyelin via sphingomyelin synthase 1/2 (SMS1/2).
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degradation require bacterial components since inhibition
of bacterial transcription and translation interfere with
these processes [82]. Interestingly, Chlamydia may use
preformed early secreted or surface presented effectors to
prevent lysosomal degradation as lysosomal maturation is
delayed even in the presence of bacterial translation inhib-
itors [83]. Only a limited number of early chlamydial effec-
tors have yet been characterized. Tarp and CT694, two of
these effectors involved in actin modulation have been dis-
cussed in the previous section. A recent report describes
ChlaOTU as another early effector with deubiquitinating
activity [84]. Formation of endosomes with C. caviae is ac-
companied by extensive ubiquitination, which is likely re-
moved through the action of ChlaOTU. Interaction
between ChlaOTU and host autophagy receptor NDP52
has been observed but appears to be dispensable for infec-
tion [84]. ChlaOTU is well conserved in C. pneumoniae
but homology in C. trachomatis and C. muridarum is
weak [84]. Transport of early inclusions of C. trachomatis
and C. pneumoniae proceeds in a microtubule and Src
family kinase dependent manner resulting in transport to
the microtubule organizing center (MTOC) [85-87]. Inter-
estingly, inclusions of the nonhuman chlamydial species
C. caviae and C. muridarum are not transported to the
MTOC [87]. Transport to the MTOC requires host cell
vesicle transport and is dynein dependent but p50 dynami-
tin independent, as was shown by microinjection of anti-
bodies against these proteins [86]. Antibodies directed
against the plus end motor protein kinesin did not affect
the transport while p150 (Glued) (subunit of the dynactin
complex) co-localized to the endosome. The absence of
p50 dynamitin which links vesicular cargo to dynein sug-
gests that a bacterial factor within the endosomal mem-
brane exerts this function [86]. During transport to the
MTOC, the Chlamydia-containing endosome quickly de-
viates from the endosomal route, i.e. it is negative for
endosomal fluid phase as well as lysosomal markers
[88,89]. The exocytic Golgi to plasma membrane pathway
is interrupted and Chlamydia-harboring endosome aquires
sphingomyelin [17,80]. Interruption of Golgi derived exo-
cytic transport might require the manipulation of small
Rab GTPases, e.g. it has been shown that sphingomyelin
acquisition is controlled by Rab14 around 10 hours post
infection [90]. It remains to be investigated whether this
process is controlled via interaction with early-secreted
bacterial proteins, however, most of the investigated small
Rab GTPases are recruited to the maturing inclusion [91].
Rab GTPases are selectively recruited in a species-
dependent and -independent manner, probably through
interaction with inclusion membrane proteins [91]. Select-
ive recruitment of Rab GTPases regulates the interaction
with various host organelles and this is supported by
recruitment of several Rab interactors e.g. Bicaudal D1(Rab 6 interactor), oculocerebrorenal syndrome of Lowe
(OCRL1, interacts with multiple Rabs) and RAB11 family
interacting protein 2 (Rab11FIP2, Rab11 and 14 interactor)
[92-94]. Intracellular development of the inclusion is ac-
companied by extensive lipid acquisition from various
sources. One of the major lipid sources appears to be the
Golgi apparatus [17,95,96] that is fragmented during C.
trachomatis infection probably to facilitate lipid transport
to the inclusion [97]. Fragmentation of the Golgi and cer-
amide acquisition has been suggested to depend on Rab6/
11 [98] and this process might be specific for C. trachomatis
as it was not yet described for any other chlamydial spe-
cies. The Golgi as the major lipid source is supported by
preferential interception of basolaterally directed Golgi de-
rived exocytic vesicles and recruitment of the trans-Golgi
Snare syntaxin 6 (STX6) to the inclusion [99,100]. In line
with this, Chlamydia intercepts retrograde intra-Golgi traf-
ficking through recruitment of GS15 positive Conserved
Oligomeric Golgi (COG) complex vesicles [101]. Addition-
ally, optimal growth requires control of lipid trafficking
from CD63-positive late endocytic multivesicular bodies,
acquisition of cytoplasmic lipid droplets as well as recruit-
ment of the high density lipoprotein (HDL) biogenesis
machinery [102-104]. Recent results obtained for C.
muridarum indicate that sphingomyelin acquisition might
proceed in both vesicle-dependent as well as independent
manner [105]. Vesicular trafficking via ADP-ribosylation
factor 1 (Arf1) and Golgi-specific brefeldin A resistance
factor 1 (GBF1) was found to be mainly required for inclu-
sion membrane growth and stability but not for bacterial
replication. Conversely, vesicular independent transport via
the lipid carrier ceramide transfer protein (CERT) which is
involved in endoplasmic reticulum (ER) to trans-Golgi
transport as well as acquisition of VAMP (vesicle-associ-
ated membrane protein)-associated protein A (VAP-A),
sphingomyelin synthase 1 and 2 (SMS1 and 2) to the inclu-
sion are required for bacterial replication [105]. The situ-
ation appears to be more complex as various trafficking
pathways regulate sphingolipid acquisition [99,106]. Eluci-
dating the complexity of trafficking and lipid acquisition
may require the establishment of fully polarized infection
models for Chlamydia infection.
Contact area - proteins in the inclusion membrane
Upon completion of invasion chlamydial proteins heavily
modify the endosomal membrane. Bacterial proteins
present in the membrane of the inclusion and directed to-
wards the cytoplasmic face of the inclusion membrane are
likely to mediate early (positioning), mid (organelle fusion,
survival control) and late (survival control, egress) effects
and thereby critically regulate replication. More than 50
chlamydial proteins were detected in the inclusion mem-
brane by immunofluorescence microscopy using specific
antibodies [107]. A characteristic feature of the inclusion
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lobed transmembrane region which is useful for the in
silico prediction of Inc proteins throughout the order of
Chlamydiales [108-113]. Inc proteins share little se-
quence identity with each other, are unique for the order
Chlamydiales and represent between 7-10% of the re-
spective species proteomes [113]. Secretion of Inc pro-
teins has been suggested to be TTSS dependent and this
has been confirmed in a heterologous Shigella and
Yersinia systems as well as by using chemical inhibitors
of TTSS [114,115].
IncA is so far the best characterized Inc protein and
has been shown to mediate inclusion fusogenicity through
interaction of its soluble N-ethylmaleimide-sensitive-factor
attachment receptor (SNARE) like cytoplasmic coiled-coil
domains forming tetramer bundles [116-119]. Propagation
of C. trachomatis was dramatically reduced in the pres-
ence of TTSS inhibitors and treatment of infected cells
with TTSS inhibitors prevented translocation of IncA as
well as inclusion fusion [120]. IncA homotypic interaction
might be the exception rather than the rule among Inc
proteins and more recent data suggest additional interac-
tions with host SNARE proteins [119]. Host proteins have
been identified as interaction partners for many of the in-
vestigated Inc proteins that could explain how Chlamydia
modulates host cell physiology. Interaction of IncG and
host 14-3-3 beta was the first described example, which
was later linked to the recruitment of phosphorylated host
Bcl-2-associated agonist of cell death (Bad) and indicated
to be one part of chlamydial interference with apoptosis
signaling [119,121] (Figure 3). Recently, Inc proteins were
identified as regulators of species-specific Rab GTPase
inclusion recruitment [91]. CT229 was found to interact
with Rab4, while Cpn0585 interacts with Rab1, 10 and
11 [122,123]. Thus, recruitment of Rab GTPases via Inc
proteins could explain inclusion-mediated regulation and
control of vesicular trafficking inside the eukaryotic
host cell. A subset of Inc proteins, i.e. IncB, Inc101,
Inc222 and Inc850 have been shown to associate with
active Src family kinases (SFK) in micro-domains and
this regulates interaction with the microtubule network
and maybe even SFK-mediated sphingolipid acquisition
[106,124]. IncD interaction with CERT represents another
example of how Chlamydia exerts control over sphin-
golipid acquisition and suggests a bridging function
at inclusion ER junction sites between IncD, CERT
and VAPs [125,126].
Finally, exit mechanisms might also be governed
through Inc interactions as shown for the interaction be-
tween CT228 and Myosin phosphatase-targeting subunit
1 (MYPT1) [127]. Chlamydial host cell exit takes place
either through a series of cysteine protease mediated
proteolytic steps or extrusion, which describes an actin,
N-Wasp, Myosin-II and Rho GTPase-dependent exitmechanism [18]. Both, the active as well as inactive
forms of MYPT1 were recruited to the inclusion mem-
brane. Phosphorylated inactive MYPT1 co-localized in
SFK micro domains with myosin light chain 2 (MLC2),
myosin light chain kinase (MLCK), myosin IIA and B.
Inactivation of either MLC2, MLCK, myosin IIA or B re-
duced chlamydial extrusion; thus, the suggested role of
CT228 mediated MYPT1 regulation is a shift of exit
mechanism in response to certain environmental stimuli
[127]. These examples suggest that understanding the
function of chlamydial Inc and host protein complexes
will be key for a deeper understanding on the mechan-
ism how Chlamydia modulates the host cell. This as-
sumption asks for a systematic investigation of Inc
proteins and inclusion membrane content.
Future directions
Due to the unique intracellular lifestyle in a membrane-
bound vacuolar environment, Chlamydia spp. have to
exploit various routes of invasion and mechanisms to
maintain their niche. Here, we have summarized how
Chlamydia modulates cellular signaling and membrane
trafficking. It is apparent that significant effort is re-
quired to fully understand how Chlamydia occupies its
niche. Some of the open tasks are e.g. identification of
the adhesin host receptor repertoire, clarification of the
first steps of invasion, species specificity, infection of po-
larized epithelial cells and transfer into in vivo models.
Further, although the number of proteins interacting
with the bacterial factors is constantly growing, func-
tional analysis of these interactions is still in its infancy
and awaiting the full use of the newly developed chla-
mydial genetics. Applying the power of forward genetic
approaches will help to identify bacterial effectors that
orchestrate the complex chlamydial adaptation in its
unique niche inside the host cell.
Abbreviations
EB: Elementary bodies; RB: Reticulate bodies.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
AM and TR: drafted and revised the manuscript. Both authors read and
approved the final manuscript.
Acknowledgments
We thank Andreas Demuth for comments and corrections. This work was
supported through the DFG priority program SPP1580 to A.M. and T.R. This
publication was funded by the German Research Foundation (DFG) and the
University of Wuerzburg in the funding programme Open Access Publishing.
Received: 8 August 2013 Accepted: 19 November 2013
Published: 22 November 2013
Reference
1. Everett KD, Bush RM, Andersen AA: Emended description of the order
Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae
fam. nov., each containing one monotypic genus, revised taxonomy of
Mehlitz and Rudel Cell Communication and Signaling 2013, 11:90 Page 9 of 11
http://www.biosignaling.com/content/11/1/90the family Chlamydiaceae, including a new genus and five new species,
and standards for the identification of organisms. Int J Syst Bacteriol 1999,
49 Pt 2:415–440.
2. Thom DH, Grayston JT, Wang SP, Kuo CC, Altman J: Chlamydia
pneumoniae strain TWAR, Mycoplasma pneumoniae, and viral infections
in acute respiratory disease in a university student health clinic
population. Am J Epidemiol 1990, 132:248–256.
3. Campbell LA, Kuo CC, Wang SP, Grayston JT: Serological response to
Chlamydia pneumoniae infection. J Clin Microbiol 1990, 28:1261–1264.
4. Littman AJ, Jackson LA, Vaughan TL: Chlamydia pneumoniae and lung
cancer: epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 2005,
14:773–778.
5. Mahony JB, Coombes BK: Chlamydia pneumoniae and atherosclerosis:
does the evidence support a causal or contributory role? FEMS Microbiol
Lett 2001, 197:1–9.
6. Henrichfreise B, Schiefer A, Schneider T, Nzukou E, Poellinger C, Hoffmann
TJ, Johnston KL, Moelleken K, Wiedemann I, Pfarr K, et al: Functional
conservation of the lipid II biosynthesis pathway in the cell wall-less
bacteria Chlamydia and Wolbachia: why is lipid II needed? Mol Microbiol
2009, 73:913–923.
7. Omsland A, Sager J, Nair V, Sturdevant DE, Hackstadt T: Developmental stage-
specific metabolic and transcriptional activity of Chlamydia trachomatis in
an axenic medium. Proc Natl Acad Sci U S A 2012, 109:19781–19785.
8. Clifton DR, Fields KA, Grieshaber SS, Dooley CA, Fischer ER, Mead DJ,
Carabeo RA, Hackstadt T: A chlamydial type III translocated protein is
tyrosine-phosphorylated at the site of entry and associated with
recruitment of actin. Proc Natl Acad Sci U S A 2004, 101:10166–10171.
9. Hower S, Wolf K, Fields KA: Evidence that CT694 is a novel Chlamydia
trachomatis T3S substrate capable of functioning during invasion or
early cycle development. Mol Microbiol 2009, 72:1423–1437.
10. Markham AP, Jaafar ZA, Kemege KE, Middaugh CR, Hefty PS: Biophysical
characterization of Chlamydia trachomatis CT584 supports its potential
role as a type III secretion needle tip protein. Biochemistry 2009,
48:10353–10361.
11. Stone CB, Bulir DC, Emdin CA, Pirie RM, Porfilio EA, Slootstra JW, Mahony JB:
Chlamydia pneumoniae CdsL regulates CdsN ATPase activity, and
disruption with a peptide mimetic prevents bacterial invasion.
Front Microbiol 2011, 2:21.
12. Molleken K, Becker E, Hegemann JH: The Chlamydia pneumoniae invasin
protein Pmp21 recruits the EGF receptor for host cell entry. PLoS Pathog
2013, 9:e1003325.
13. Scidmore-Carlson MA, Shaw EI, Dooley CA, Fischer ER, Hackstadt T:
Identification and characterization of a Chlamydia trachomatis early
operon encoding four novel inclusion membrane proteins. Mol Microbiol
1999, 33:753–765.
14. Al-Younes HM, Rudel T, Brinkmann V, Szczepek AJ, Meyer TF: Low iron
availability modulates the course of Chlamydia pneumoniae infection.
Cell Microbiol 2001, 3:427–437.
15. Rockey DD, Heinzen RA, Hackstadt T: Cloning and characterization of a
Chlamydia psittaci gene coding for a protein localized in the inclusion
membrane of infected cells. Mol Microbiol 1995, 15:617–626.
16. Ojcius DM, Hellio R, Dautry-Varsat A: Distribution of endosomal, lysosomal,
and major histocompatability complex markers in a monocytic cell line
infected with Chlamydia psittaci. Infect Immun 1997, 65:2437–2442.
17. Hackstadt T, Rockey DD, Heinzen RA, Scidmore MA: Chlamydia trachomatis
interrupts an exocytic pathway to acquire endogenously synthesized
sphingomyelin in transit from the Golgi apparatus to the plasma
membrane. EMBO J 1996, 15:964–977.
18. Hybiske K, Stephens RS: Mechanisms of host cell exit by the intracellular
bacterium Chlamydia. Proc Natl Acad Sci U S A 2007, 104:11430–11435.
19. Chin E, Kirker K, Zuck M, James G, Hybiske K: Actin recruitment to the
Chlamydia inclusion is spatiotemporally regulated by a mechanism that
requires host and bacterial factors. PLoS One 2012, 7:e46949.
20. Wyrick PB: Chlamydia trachomatis persistence in vitro: an overview.
J Infect Dis 2010, 201(Suppl 2):S88–S95.
21. Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P:
Chlamydial persistence: beyond the biphasic paradigm. Infect Immun
2004, 72:1843–1855.
22. Belland RJ, Zhong G, Crane DD, Hogan D, Sturdevant D, Sharma J, Beatty WL,
Caldwell HD: Genomic transcriptional profiling of the developmental cycle
of Chlamydia trachomatis. Proc Natl Acad Sci U S A 2003, 100:8478–8483.23. Maurer AP, Mehlitz A, Mollenkopf HJ, Meyer TF: Gene expression profiles of
Chlamydophila pneumoniae during the developmental cycle and iron
depletion-mediated persistence. PLoS Pathog 2007, 3:e83.
24. Peters J, Wilson DP, Myers G, Timms P, Bavoil PM: Type III secretion a la
Chlamydia. Trends Microbiol 2007, 15:241–251.
25. Beeckman DS, Vanrompay DC: Bacterial secretion systems with an emphasis
on the chlamydial Type III secretion system. Curr Issues Mol Biol 2010, 12:17–41.
26. Wehrl W, Brinkmann V, Jungblut PR, Meyer TF, Szczepek AJ: From the
inside out–processing of the Chlamydial autotransporter PmpD and its
role in bacterial adhesion and activation of human host cells.
Mol Microbiol 2004, 51:319–334.
27. Moelleken K, Hegemann JH: The Chlamydia outer membrane protein
OmcB is required for adhesion and exhibits biovar-specific differences in
glycosaminoglycan binding. Mol Microbiol 2008, 67:403–419.
28. Tan M, Bavoil PM: Intracellular Pathogens I: Chlamydiales. Washington,
D.C.: ASM Press; 2012.
29. Campbell LA, Kuo CC: Interactions of chlamydia with the host cells that
mediate attachment and uptake. Chlamydia genomics and
pathogenesis. Horizon Bioscience 2006, 1:505–522.
30. Moelleken K, Hegemann JH: Chlamydial adhesion and adhesins. In
Intracellular Pathogens I: Chlamydiales. Edited by Tan M, Bavoil PM.
Washington, D.C.: ASM Press; 2012.
31. Su H, Watkins NG, Zhang YX, Caldwell HD: Chlamydia trachomatis-host cell
interactions: role of the chlamydial major outer membrane protein as an
adhesin. Infect Immun 1990, 58:1017–1025.
32. Su H, Caldwell HD: In vitro neutralization of Chlamydia trachomatis by
monovalent Fab antibody specific to the major outer membrane
protein. Infect Immun 1991, 59:2843–2845.
33. Su H, Raymond L, Rockey DD, Fischer E, Hackstadt T, Caldwell HD:
A recombinant Chlamydia trachomatis major outer membrane protein
binds to heparan sulfate receptors on epithelial cells. Proc Natl Acad Sci
U S A 1996, 93:11143–11148.
34. Swanson AF, Kuo CC: Evidence that the major outer membrane protein of
Chlamydia trachomatis is glycosylated. Infect Immun 1991, 59:2120–2125.
35. Swanson AF, Kuo CC: Binding of the glycan of the major outer membrane
protein of Chlamydia trachomatis to HeLa cells. Infect Immun 1994, 62:24–28.
36. Kuo C, Takahashi N, Swanson AF, Ozeki Y, Hakomori S: An N-linked high-
mannose type oligosaccharide, expressed at the major outer membrane
protein of Chlamydia trachomatis, mediates attachment and infectivity
of the microorganism to HeLa cells. J Clin Invest 1996, 98:2813–2818.
37. Puolakkainen M, Kuo CC, Campbell LA: Chlamydia pneumoniae uses the
mannose 6-phosphate/insulin-like growth factor 2 receptor for infection
of endothelial cells. Infect Immun 2005, 73:4620–4625.
38. Zhang JP, Stephens RS: Mechanism of C. trachomatis attachment to
eukaryotic host cells. Cell 1992, 69:861–869.
39. Rasmussen-Lathrop SJ, Koshiyama K, Phillips N, Stephens RS: Chlamydia-
dependent biosynthesis of a heparan sulphate-like compound in
eukaryotic cells. Cell Microbiol 2000, 2:137–144.
40. Stephens RS, Poteralski JM, Olinger L: Interaction of Chlamydia
trachomatis with mammalian cells is independent of host cell surface
heparan sulfate glycosaminoglycans. Infect Immun 2006, 74:1795–1799.
41. Stephens RS, Koshiyama K, Lewis E, Kubo A: Heparin-binding outer
membrane protein of chlamydiae. Mol Microbiol 2001, 40:691–699.
42. Fadel S, Eley A: Chlamydia trachomatis OmcB protein is a surface-exposed
glycosaminoglycan-dependent adhesin. J Med Microbiol 2007, 56:15–22.
43. Fadel S, Eley A: Differential glycosaminoglycan binding of Chlamydia
trachomatis OmcB protein from serovars E and LGV. J Med Microbiol
2008, 57:1058–1061.
44. Fechtner T, Stallmann S, Moelleken K, Meyer KL, Hegemann JH:
Characterization of the interaction between the chlamydial adhesin
OmcB and the human host cell. J Bacteriol 2013, 195(23):5323–5333.
45. Beswick EJ, Travelstead A, Cooper MD: Comparative studies of
glycosaminoglycan involvement in Chlamydia pneumoniae and C.
trachomatis invasion of host cells. J Infect Dis 2003, 187:1291–1300.
46. Fudyk T, Olinger L, Stephens RS: Selection of mutant cell lines resistant to
infection by Chlamydia spp [corrected]. Infect Immun 2002, 70:6444–6447.
47. Conant CG, Stephens RS: Chlamydia attachment to mammalian cells
requires protein disulfide isomerase. Cell Microbiol 2007, 9:222–232.
48. Rosmarin DM, Carette JE, Olive AJ, Starnbach MN, Brummelkamp TR, Ploegh
HL: Attachment of Chlamydia trachomatis L2 to host cells requires
sulfation. Proc Natl Acad Sci U S A 2012, 109:10059–10064.
Mehlitz and Rudel Cell Communication and Signaling 2013, 11:90 Page 10 of 11
http://www.biosignaling.com/content/11/1/9049. Ajonuma LC, Fok KL, Ho LS, Chan PK, Chow PH, Tsang LL, Wong CH, Chen J,
Li S, Rowlands DK, et al: CFTR is required for cellular entry and
internalization of Chlamydia trachomatis. Cell Biol Int 2010, 34:593–600.
50. Kim JH, Jiang S, Elwell CA, Engel JN: Chlamydia trachomatis co-opts the FGF2
signaling pathway to enhance infection. PLoS Pathog 2011, 7:e1002285.
51. Coombes BK, Mahony JB: Identification of MEK- and phosphoinositide
3-kinase-dependent signalling as essential events during Chlamydia
pneumoniae invasion of HEp2 cells. Cell Microbiol 2002, 4:447–460.
52. Elwell CA, Ceesay A, Kim JH, Kalman D, Engel JN: RNA interference screen
identifies Abl kinase and PDGFR signaling in Chlamydia trachomatis
entry. PLoS Pathog 2008, 4:e1000021.
53. Mehlitz A, Banhart S, Maurer AP, Kaushansky A, Gordus AG, Zielecki J,
Macbeath G, Meyer TF: Tarp regulates early Chlamydia-induced host cell
survival through interactions with the human adaptor protein SHC1.
J Cell Biol 2010, 190:143–157.
54. Lane BJ, Mutchler C, Al Khodor S, Grieshaber SS, Carabeo RA: Chlamydial
entry involves TARP binding of guanine nucleotide exchange factors.
PLoS Pathog 2008, 4:e1000014.
55. Jewett TJ, Dooley CA, Mead DJ, Hackstadt T: Chlamydia trachomatis tarp is
phosphorylated by src family tyrosine kinases. Biochem Biophys Res
Commun 2008, 371:339–344.
56. Mehlitz A, Banhart S, Hess S, Selbach M, Meyer TF: Complex kinase
requirements for Chlamydia trachomatis Tarp phosphorylation.
FEMS Microbiol Lett 2008, 289:233–240.
57. Reynolds DJ, Pearce JH: Characterization of the cytochalasin D-resistant
(pinocytic) mechanisms of endocytosis utilized by chlamydiae.
Infect Immun 1990, 58:3208–3216.
58. Schramm N, Wyrick PB: Cytoskeletal requirements in Chlamydia
trachomatis infection of host cells. Infect Immun 1995, 63:324–332.
59. Carabeo RA, Grieshaber SS, Fischer E, Hackstadt T: Chlamydia trachomatis
induces remodeling of the actin cytoskeleton during attachment and
entry into HeLa cells. Infect Immun 2002, 70:3793–3803.
60. Brinkworth AJ, Malcolm DS, Pedrosa AT, Roguska K, Shahbazian S, Graham
JE, Hayward RD, Carabeo RA: Chlamydia trachomatis Slc1 is a type III
secretion chaperone that enhances the translocation of its invasion
effector substrate TARP. Mol Microbiol 2011, 82:131–144.
61. Jamison WP, Hackstadt T: Induction of type III secretion by cell-free Chlamydia
trachomatis elementary bodies. Microb Pathog 2008, 45:435–440.
62. Clifton DR, Dooley CA, Grieshaber SS, Carabeo RA, Fields KA, Hackstadt T:
Tyrosine phosphorylation of the chlamydial effector protein Tarp is
species specific and not required for recruitment of actin. Infect Immun
2005, 73:3860–3868.
63. Jewett TJ, Fischer ER, Mead DJ, Hackstadt T: Chlamydial TARP is a bacterial
nucleator of actin. Proc Natl Acad Sci U S A 2006, 103:15599–15604.
64. Jewett TJ, Miller NJ, Dooley CA, Hackstadt T: The conserved Tarp actin binding
domain is important for chlamydial invasion. PLoS Pathog 2010, 6:e1000997.
65. Jiwani S, Alvarado S, Ohr RJ, Romero A, Nguyen B, Jewett TJ: Chlamydia
trachomatis Tarp harbors distinct G and F actin binding domains that
bundle actin filaments. J Bacteriol 2013, 195:708–716.
66. Jiwani S, Ohr RJ, Fischer ER, Hackstadt T, Alvarado S, Romero A, Jewett TJ:
Chlamydia trachomatis Tarp cooperates with the Arp2/3 complex to
increase the rate of actin polymerization. Biochem Biophys Res Commun
2012, 420:816–821.
67. Bullock HD, Hower S, Fields KA: Domain analyses reveal that Chlamydia
trachomatis CT694 protein belongs to the membrane-localized family of
type III effector proteins. J Biol Chem 2012, 287:28078–28086.
68. Carabeo RA, Grieshaber SS, Hasenkrug A, Dooley C, Hackstadt T:
Requirement for the Rac GTPase in Chlamydia trachomatis invasion of
non-phagocytic cells. Traffic 2004, 5:418–425.
69. Carabeo RA, Dooley CA, Grieshaber SS, Hackstadt T: Rac interacts with
Abi-1 and WAVE2 to promote an Arp2/3-dependent actin recruitment
during chlamydial invasion. Cell Microbiol 2007, 9:2278–2288.
70. Subtil A, Wyplosz B, Balana ME, Dautry-Varsat A: Analysis of Chlamydia
caviae entry sites and involvement of Cdc42 and Rac activity. J Cell Sci
2004, 117:3923–3933.
71. Balana ME, Niedergang F, Subtil A, Alcover A, Chavrier P, Dautry-Varsat A:
ARF6 GTPase controls bacterial invasion by actin remodelling. J Cell Sci
2005, 118:2201–2210.
72. Norkin LC, Wolfrom SA, Stuart ES: Association of caveolin with Chlamydia
trachomatis inclusions at early and late stages of infection. Exp Cell Res
2001, 266:229–238.73. Stuart ES, Webley WC, Norkin LC: Lipid rafts, caveolae, caveolin-1, and
entry by Chlamydiae into host cells. Exp Cell Res 2003, 287:67–78.
74. Jutras I, Abrami L, Dautry-Varsat A: Entry of the lymphogranuloma venereum
strain of Chlamydia trachomatis into host cells involves cholesterol-rich
membrane domains. Infect Immun 2003, 71:260–266.
75. Hybiske K, Stephens RS: Mechanisms of Chlamydia trachomatis entry into
nonphagocytic cells. Infect Immun 2007, 75:3925–3934.
76. Majeed M, Kihlstrom E: Mobilization of F-actin and clathrin during
redistribution of Chlamydia trachomatis to an intracellular site in
eucaryotic cells. Infect Immun 1991, 59:4465–4472.
77. Boleti H, Benmerah A, Ojcius DM, Cerf-Bensussan N, Dautry-Varsat A:
Chlamydia infection of epithelial cells expressing dynamin and Eps15
mutants: clathrin-independent entry into cells and dynamin-dependent
productive growth. J Cell Sci 1999, 112(Pt 10):1487–1496.
78. Gabel BR, Elwell C, van Ijzendoorn SC, Engel JN: Lipid raft-mediated entry
is not required for Chlamydia trachomatis infection of cultured epithelial
cells. Infect Immun 2004, 72:7367–7373.
79. Lakadamyali M, Rust MJ, Zhuang X: Endocytosis of influenza viruses.
Microbes Infect 2004, 6:929–936.
80. Wolf K, Hackstadt T: Sphingomyelin trafficking in Chlamydia pneumoniae-
infected cells. Cell Microbiol 2001, 3:145–152.
81. Schramm N, Bagnell CR, Wyrick PB: Vesicles containing Chlamydia
trachomatis serovar L2 remain above pH 6 within HEC-1B cells.
Infect Immun 1996, 64:1208–1214.
82. Scidmore MA, Rockey DD, Fischer ER, Heinzen RA, Hackstadt T: Vesicular
interactions of the Chlamydia trachomatis inclusion are determined by
chlamydial early protein synthesis rather than route of entry.
Infect Immun 1996, 64:5366–5372.
83. Scidmore MA, Fischer ER, Hackstadt T: Restricted fusion of Chlamydia
trachomatis vesicles with endocytic compartments during the initial
stages of infection. Infect Immun 2003, 71:973–984.
84. Furtado AR, Essid M, Perrinet S, Balana ME, Yoder N, Dehoux P, Subtil A:
The chlamydial OTU domain-containing protein ChlaOTU is an early type
III secretion effector targeting ubiquitin and NDP52. Cell Microbiol 2013,
15(12):2064–2079.
85. Clausen JD, Christiansen G, Holst HU, Birkelund S: Chlamydia trachomatis
utilizes the host cell microtubule network during early events of
infection. Mol Microbiol 1997, 25:441–449.
86. Grieshaber SS, Grieshaber NA, Hackstadt T: Chlamydia trachomatis uses
host cell dynein to traffic to the microtubule-organizing center in a p50
dynamitin-independent process. J Cell Sci 2003, 116:3793–3802.
87. Mital J, Hackstadt T: Diverse requirements for SRC-family tyrosine kinases
distinguish chlamydial species. MBio 2011. doi: 10.1128/mBio.00031-11.
88. Heinzen RA, Scidmore MA, Rockey DD, Hackstadt T: Differential interaction
with endocytic and exocytic pathways distinguish parasitophorous
vacuoles of Coxiella burnetii and Chlamydia trachomatis. Infect Immun
1996, 64:796–809.
89. Al Younes HM, Rudel T, Meyer TF: Characterization and intracellular
trafficking pattern of vacuoles containing Chlamydia pneumoniae in
human epithelial cells. Cell Microbiol 1999, 1:237–247.
90. Capmany A, Damiani MT: Chlamydia trachomatis intercepts Golgi-derived
sphingolipids through a Rab14-mediated transport required for bacterial
development and replication. PloS one 2010, 5:e14084.
91. Rzomp KA, Scholtes LD, Briggs BJ, Whittaker GR, Scidmore MA: Rab GTPases
are recruited to chlamydial inclusions in both a species-dependent and
species-independent manner. Infect Immun 2003, 71:5855–5870.
92. Moorhead AM, Jung JY, Smirnov A, Kaufer S, Scidmore MA: Multiple host
proteins that function in phosphatidylinositol-4-phosphate metabolism
are recruited to the chlamydial inclusion. Infect Immun 2010,
78:1990–2007.
93. Moorhead AR, Rzomp KA, Scidmore MA: The Rab6 effector Bicaudal D1
associates with Chlamydia trachomatis inclusions in a biovar-specific
manner. Infect Immun 2007, 75:781–791.
94. Leiva N, Capmany A, Damiani MT: Rab11-family of interacting protein 2
associates with chlamydial inclusions through its Rab-binding domain
and promotes bacterial multiplication. Cell Microbiol 2013, 15:114–129.
95. Carabeo RA, Mead DJ, Hackstadt T: Golgi-dependent transport of
cholesterol to the Chlamydia trachomatis inclusion. Proc Natl Acad Sci
U S A 2003, 100:6771–6776.
96. Hackstadt T, Scidmore MA, Rockey DD: Lipid metabolism in Chlamydia
trachomatis-infected cells: directed trafficking of Golgi-derived
Mehlitz and Rudel Cell Communication and Signaling 2013, 11:90 Page 11 of 11
http://www.biosignaling.com/content/11/1/90sphingolipids to the chlamydial inclusion. Proc Natl Acad Sci U S A 1995,
92:4877–4881.
97. Heuer D, Lipinski AR, Machuy N, Karlas A, Wehrens A, Siedler F, Brinkmann V,
Meyer TF: Chlamydia causes fragmentation of the Golgi compartment to
ensure reproduction. Nature 2009, 457:731–735.
98. Rejman Lipinski A, Heymann J, Meissner C, Karlas A, Brinkmann V, Meyer TF,
Heuer D: Rab6 and Rab11 regulate Chlamydia trachomatis development
and golgin-84-dependent Golgi fragmentation. PLoS Pathog 2009,
5:e1000615.
99. Moore ER, Fischer ER, Mead DJ, Hackstadt T: The chlamydial inclusion
preferentially intercepts basolaterally directed sphingomyelin-containing
exocytic vacuoles. Traffic 2008, 9:2130–2140.
100. Moore ER, Mead DJ, Dooley CA, Sager J, Hackstadt T: The trans-Golgi
SNARE syntaxin 6 is recruited to the chlamydial inclusion membrane.
Microbiology 2011, 157:830–838.
101. Pokrovskaya ID, Szwedo JW, Goodwin A, Lupashina TV, Nagarajan UM,
Lupashin VV: Chlamydia trachomatis hijacks intra-Golgi COG complex-
dependent vesicle trafficking pathway. Cell Microbiol 2012, 14:656–668.
102. Beatty WL: Trafficking from CD63-positive late endocytic multivesicular
bodies is essential for intracellular development of Chlamydia
trachomatis. J Cell Sci 2006, 119:350–359.
103. Cocchiaro JL, Kumar Y, Fischer ER, Hackstadt T, Valdivia RH: Cytoplasmic
lipid droplets are translocated into the lumen of the Chlamydia
trachomatis parasitophorous vacuole. Proc Natl Acad Sci U S A 2008,
105:9379–9384.
104. Cox JV, Naher N, Abdelrahman YM, Belland RJ: Host HDL biogenesis
machinery is recruited to the inclusion of Chlamydia trachomatis-
infected cells and regulates chlamydial growth. Cell Microbiol 2012,
14:1497–1512.
105. Elwell CA, Jiang S, Kim JH, Lee A, Wittmann T, Hanada K, Melancon P,
Engel JN: Chlamydia trachomatis co-opts GBF1 and CERT to acquire host
sphingomyelin for distinct roles during intracellular development.
PLoS Pathog 2011, 7:e1002198.
106. Mital J, Hackstadt T: Role for the SRC family kinase Fyn in sphingolipid
acquisition by chlamydiae. Infect Immun 2011, 79:4559–4568.
107. Li Z, Chen C, Chen D, Wu Y, Zhong Y, Zhong G: Characterization of fifty
putative inclusion membrane proteins encoded in the Chlamydia
trachomatis genome. Infect Immun 2008, 76:2746–2757.
108. Bannantine JP, Stamm WE, Suchland RJ, Rockey DD: Chlamydia
trachomatis IncA is localized to the inclusion membrane and is
recognized by antisera from infected humans and primates.
Infect Immun 1998, 66:6017–6021.
109. Bannantine JP, Griffiths RS, Viratyosin W, Brown WJ, Rockey DD:
A secondary structure motif predictive of protein localization to the
chlamydial inclusion membrane. Cell Microbiol 2000, 2:35–47.
110. Toh H, Miura K, Shirai M, Hattori M: In silico inference of inclusion
membrane protein family in obligate intracellular parasites chlamydiae.
DNA Res 2003, 10:9–17.
111. Heinz E, Rockey DD, Montanaro J, Aistleitner K, Wagner M, Horn M:
Inclusion membrane proteins of Protochlamydia amoebophila UWE25
reveal a conserved mechanism for host cell interaction among the
Chlamydiae. J Bacteriol 2010, 192:5093–5102.
112. Lutter EI, Martens C, Hackstadt T: Evolution and conservation of predicted
inclusion membrane proteins in chlamydiae. Comp Funct Genomics 2012,
2012:362104.
113. Dehoux P, Flores R, Dauga C, Zhong G, Subtil A: Multi-genome
identification and characterization of chlamydiae-specific type III secre-
tion substrates: the Inc proteins. BMC Genomics 2011, 12:109.
114. Subtil A, Parsot C, Dautry-Varsat A: Secretion of predicted Inc proteins of
Chlamydia pneumoniae by a heterologous type III machinery.
Mol Microbiol 2001, 39:792–800.
115. Fields KA, Mead DJ, Dooley CA, Hackstadt T: Chlamydia trachomatis type III
secretion: evidence for a functional apparatus during early-cycle
development. Mol Microbiol 2003, 48:671–683.
116. Suchland RJ, Rockey DD, Bannantine JP, Stamm WE: Isolates of Chlamydia
trachomatis that occupy nonfusogenic inclusions lack IncA, a protein
localized to the inclusion membrane. Infect Immun 2000, 68:360–367.
117. Alzhanov D, Barnes J, Hruby DE, Rockey DD: Chlamydial development is
blocked in host cells transfected with Chlamydophila caviae incA.
BMC Microbiol 2004, 4:24.118. Delevoye C, Nilges M, Dautry-Varsat A, Subtil A: Conservation of the biochemical
properties of IncA from Chlamydia trachomatis and Chlamydia caviae:
oligomerization of IncA mediates interaction between facing membranes.
J Biol Chem 2004, 279:46896–46906.
119. Delevoye C, Nilges M, Dehoux P, Paumet F, Perrinet S, Dautry-Varsat A,
Subtil A: SNARE protein mimicry by an intracellular bacterium. PLoS
Pathog 2008, 4:e1000022.
120. Muschiol S, Bailey L, Gylfe A, Sundin C, Hultenby K, Bergstrom S, Elofsson M,
Wolf-Watz H, Normark S, Henriques-Normark B: A small-molecule inhibitor
of type III secretion inhibits different stages of the infectious cycle of
Chlamydia trachomatis. Proc Natl Acad Sci U S A 2006, 103:14566–14571.
121. Verbeke P, Welter-Stahl L, Ying S, Hansen J, Hacker G, Darville T, Ojcius DM:
Recruitment of BAD by the Chlamydia trachomatis vacuole correlates
with host-cell survival. PLoS Pathog 2006, 2:e45.
122. Cortes C, Rzomp KA, Tvinnereim A, Scidmore MA, Wizel B: Chlamydia
pneumoniae inclusion membrane protein Cpn0585 interacts with
multiple Rab GTPases. Infect Immun 2007, 75:5586–5596.
123. Rzomp KA, Moorhead AR, Scidmore MA: The GTPase Rab4 interacts with
Chlamydia trachomatis inclusion membrane protein CT229. Infect Immun
2006, 74:5362–5373.
124. Mital J, Miller NJ, Fischer ER, Hackstadt T: Specific chlamydial inclusion
membrane proteins associate with active Src family kinases in
microdomains that interact with the host microtubule network.
Cell Microbiol 2010, 12:1235–1249.
125. Derre I, Swiss R, Agaisse H: The lipid transfer protein CERT interacts with
the Chlamydia inclusion protein IncD and participates to ER-Chlamydia
inclusion membrane contact sites. PLoS Pathog 2011, 7:e1002092.
126. Dumoux M, Clare DK, Saibil HR, Hayward RD: Chlamydiae assemble a
pathogen synapse to hijack the host endoplasmic reticulum. Traffic 2012,
13:1612–1627.
127. Lutter EI, Barger AC, Nair V, Hackstadt T: Chlamydia trachomatis Inclusion
Membrane Protein CT228 Recruits Elements of the Myosin Phosphatase
Pathway to Regulate Release Mechanisms. Cell Rep 2013, 3:1921–1931.
doi:10.1186/1478-811X-11-90
Cite this article as: Mehlitz and Rudel: Modulation of host signaling and
cellular responses by Chlamydia. Cell Communication and Signaling
2013 11:90.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
